Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5962
    +0.0025 (+0.43%)
     
  • NZD/EUR

    0.5558
    +0.0012 (+0.21%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.85
    +0.04 (+0.05%)
     
  • GOLD

    2,338.50
    +0.10 (+0.00%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,090.97
    +50.59 (+0.63%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,991.94
    -96.76 (-0.53%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.7870
    +0.6720 (+0.73%)
     

Company News for Oct 1, 2021

  • Paychex, Inc.’s PAYX shares rose 4.3% after the company reported first-quarter of fiscal 2022 earnings of 89 cents per share, surpassing the Zacks Consensus Estimate of 81 cents.

  • Shares of Virgin Galactic Holdings, Inc. SPCE surged 12.2% after the company reported that it was cleared to fly FAA-licensed spaceflights after the conclusion of FAA inquiry on the Unity 22 flight that took place in July.

  • Alzamend Neuro, Inc.’s ALZN shares surged 35.1% after the company reported that it has received a pre-IND response from the FDA for AL002, a cell-based therapeutic vaccine that aims to restore the ability of patients' immunological system to combat Alzheimer's disease.

  • Shares of Onion Global Limited OG jumped 30% after the company announced plans to launch the LUCA Elite Club events in its KOC community to enhance distribution channel efficiency.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Paychex, Inc. (PAYX) : Free Stock Analysis Report
 
Virgin Galactic Holdings, Inc. (SPCE) : Free Stock Analysis Report
 
Onion Global Limited Unsponsored ADR (OG): Free Stock Analysis Report
 
Alzamend Neuro, Inc. (ALZN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.